middle.news
How Will Clarity’s New Copper-64 Deal Accelerate Prostate Cancer Diagnostics?
9:32am on Wednesday 25th of March, 2026 AEDT
•
Healthcare
Read Story
How Will Clarity’s New Copper-64 Deal Accelerate Prostate Cancer Diagnostics?
9:32am on Wednesday 25th of March, 2026 AEDT
Key Points
Large-scale copper-64 supply agreement signed with Theragenics
Theragenics to produce copper-64 at Atlanta facility with 14 cyclotrons
Supports commercial launch of Cu-SAR-bisPSMA after Phase III trials and FDA approval
Enhances Clarity’s US supply network alongside existing agreements
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Clarity Pharmaceuticals (ASX:CU6)
OPEN ARTICLE